Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Human (tested or 100% immunogen sequence identity)
IHC - Paraffin (3.75 µg/ml)
Specificity and Use
PRODH antibody was raised against synthetic peptide C-ERDGSGTNKRDKQYQ from an internal region of human PRODH (NP_057419.2). Percent identity by BLAST analysis: Human, Gorilla, Gibbon (100%); Marmoset, Mouse, Rat, Hamster, Elephant (87%).
LS-E26057 - Lyophilized - 100 µg - $145.00
Immunizing peptide used to generate LS-B4931. Useful for pre-absorption and neutralization of the antibody's antigen binding site.
PRODH is a mitochondrial protein that catalyzes the first step in proline degradation. Mutations in this gene are associated with hyperprolinemia type 1 and susceptibility to schizophrenia 4 (SCZD4). This gene is located on chromosome 22q11.21, a region which has also been associated with the contiguous gene deletion syndromes, DiGeorge and CATCH22. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.